Thursday, April 2, 2026
23.7 C
Bengaluru

Interview with Salil Kallianpur

[wpfilebase tag=file id=95 tpl=download-button /]

Inside this Issue

1. Interview with Salil Kallianpur  with Anup Soans, Editor – MedicinMan

“There is much work to be done and a unified pharma industry can prove to be a valuable ally to the government.”

2. Patient-centricity: How Pharma Can Move from Intention to Action by Hanno Wolfram

Patient-centricity begins with moving from talking about the patient to talking to the patient 

3. The Corporate Halo Effect by Vivek Hattangadi

How a great corporate brand elevates a company’s products in the minds of doctors and patients

4. For a Positive Attitude, Clean Your Mind’s Windows  by Asheesh Kumar Patel

A bad attitude is a learned behavior and can be unlearned when we discover it’s source

5. The Three Transformations for Leadership  by Srinivasan Athmanathan

Three key professional traits that every successful leader must possess

6. Book Review: Feather in a C.A.P. by Kamalesh Subramanian 

A corporate saga with valuable lessons for professionals of all backgrounds

Hot this week

FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare

When drones first appeared on battlefields, military establishments reacted...

Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality

Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as...

Healthcare and Gulf War: When Elephants Fight, the Grass Gets Trampled

From Gas Cylinders to ICU Beds: How the Gulf...

Semaglutide: Just Another Off-Patent Generic? Or a Different Beast Entirely?

As over 50 generic versions of the blockbuster weight-loss...

Excellence or Mediocrity—What Are You Building?

Excellence is a choice. So is Mediocrity Excellence is a...

Topics

FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare

When drones first appeared on battlefields, military establishments reacted...

Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality

Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as...

Semaglutide: Just Another Off-Patent Generic? Or a Different Beast Entirely?

As over 50 generic versions of the blockbuster weight-loss...

Excellence or Mediocrity—What Are You Building?

Excellence is a choice. So is Mediocrity Excellence is a...

Gila Monster Venom: The Unexpected Spark of the GLP-1 Revolution

In the blistering Sonoran Desert, where temperatures regularly exceed...

The Quiet Crisis in the Indian Pharma Field Force

A MedicinMan Editorial based on the Poll framed by...
spot_img

Related Articles

spot_imgspot_img